Fapon Biotech
PrivateLast Round
IPO
Feb 22, 2024
Est. Valuation
$3.48B
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Fapon Biotech operates in Healthcare & Life Sciences and is based in Dongguan. Its latest recorded funding round was a Series B round in December 2020.
Fapon Biotech is a life sciences company that provides integrated solutions and services for diagnostics, biopharma, and biotherapy, including raw materials, reagents, and open instrument platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fapon Biotech Comparables
Compare Fapon Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SD Biosensor Inc | 82% | |
| Medix Biochemica | 79% | |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 78% |
For institutional investors. Book with your work email.
Fapon Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Feb 22, 2024 | ||||
| Series B | Dec 30, 2020 | ||||
| Early Funding | Jan 1, 2019 | ||||
| Private Placement | May 10, 2017 | ||||
| Private Placement | Aug 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Fapon Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cathay Capital | Series B |
| GL Capital Group | Series B |
| Dingfeng Asset Management | Private Placement |
| 明道投资 | Private Placement |
| Huatai United Securities | IPO |
| Share Capital | Series B |
| HongShan Capital Group (HSG) | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 34% MoM.
- Jul 26, 2026
Monthly visitors increased 231% MoM.
For institutional investors. Book with your work email.
Fapon Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Fapon Biotech's valuation, stock price, and market status.
Is Fapon Biotech a public or private company?
Fapon Biotech is a private company.
What is the current stock price of Fapon Biotech?
Fapon Biotech is a private company, so its shares have no public market price. Caplight tracks Fapon Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Fapon Biotech worth (valuation)?
Fapon Biotech's valuation is estimated at $3.5B based on funding round data.
Can I buy Fapon Biotech stock?
Fapon Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Fapon Biotech's last funding round?
Fapon Biotech's most recent funding round was IPO on February 22, 2024.
Who are the main investors in Fapon Biotech?
Key investors in Fapon Biotech include Huatai United Securities.
Will Fapon Biotech IPO soon?
No public IPO plans have been announced for Fapon Biotech.
How can I track Fapon Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Fapon Biotech's shares on secondary markets.